title: [Substantiation of increasing the quality of disease-modifying therapy for multiple sclerosis using in the Russian Federation].
abstract: The problems of using disease-modifying drugs in treatment of multiple sclerosis related to the difficulties of the control over the quality of bioanalogues imported into or manufactured in the Russian Federation are discussed.
authors.affiliation: Samara State Medical University, Samara.
authors.forename: Ya V
authors.initials: YV
authors.lastname: Vlasov
authors.affiliation: Pirogov Russian National Research Medical University, Moscow; Moscow Multiple Sclerosis Center of the City Hospital #24, Moscow.
authors.forename: E V
authors.initials: EV
authors.lastname: Popova